Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Minerva ; 56(4): 405-429, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30524146

RESUMEN

In the context of more and more project-based research funding, commercialization and economic growth have increasingly become rationalized concepts that are used to demonstrate the centrality of science for societal development and prosperity. Following the world society tradition of organizational institutionalism, this paper probes the potential limits of the spread of such rationalized concepts among different types of research funders. Our comparative approach is particularly designed to study the role and position of nonprofit research funders (NPF), a comparison that is relevant as NPF could potentially be shielded from such rationalized pressures given their lack of profit gaining motives. By making a qualitative interview-based investigation we are able to describe how research funders rationalize their contributions to society at large, as well as their obligations to the researchers they fund. Four types of research funders are compared-independently wealthy philanthropists, fundraising dependent nonprofits, public agencies, and industry. We find that NPF, and especially philanthropists, are the least commercially geared type of funder, but that philanthropists also express least obligations to researchers funded. This is in sharp contrast to public research funders who, even more than industry, employ commercially geared rationalizations. We also find that both public and corporate funders express obligations to the researchers they fund. Our results indicate that there are limits to the spread of commercially tinted rationalizations among NPF, but that this does not necessarily mean an increased sense of obligations to the researchers funded, and by extension to the integrity of scientific pursuit.

2.
Stem Cell Rev Rep ; 12(1): 8-14, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26432702

RESUMEN

Nonprofit organizations and philanthropists stepped into a funding void caused by controversies over public funding of human embryonic stem cell (hESC) research. Based on interviews of 83 representatives of 53 funders, we examine the motivations and accountability structures of public agencies, corporations, fundraising dependent nonprofit organizations and philanthropic organizations that funded hESC research in three jurisdictions: California, Sweden, and South Korea. While non-traditional forms of funding are essential in the early stages of research advancement, they are unreliable for the long timeframes necessary to advance cell therapies. Such funding sources may enter the field based on high expectations, but may exit just as rapidly based on disappointing rates of progress.


Asunto(s)
Trasplante de Células/economía , Obtención de Fondos/estadística & datos numéricos , Células Madre Embrionarias Humanas/citología , Organizaciones sin Fines de Lucro/economía , Investigación con Células Madre/economía , California , Diferenciación Celular , Trasplante de Células/ética , Trasplante de Células/estadística & datos numéricos , Ensayos Clínicos como Asunto , Obtención de Fondos/ética , Células Madre Embrionarias Humanas/fisiología , Humanos , Organizaciones sin Fines de Lucro/ética , Organizaciones sin Fines de Lucro/estadística & datos numéricos , República de Corea , Investigación con Células Madre/ética , Suecia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...